US President Donald Trump announced a 100 percent tariff on “branded and patented pharmaceutical imports,” effective October 1, 2025, unless companies establish manufacturing facilities in the United States.

“Starting October 1, 2025, we will be imposing a 100 pc tariff on any branded or patented pharmaceutical product, unless a company is building its pharmaceutical manufacturing plant in America,” Trump declared on his social media platform.

Advertisement

Trump said that the new tariff would not apply to companies already “building” pharmaceutical manufacturing facilities in the United States.

“’Building’ will be defined as ‘breaking ground’ and/or ‘under construction.’ There will, therefore, be no tariff on these pharmaceutical products if construction has started,” he said.

The im

See Full Page